Electronic cigarette and moist snuff product characteristics independently associated with youth tobacco product perceptions.
Population Clinical
Perception Of Risk
Comparison With Tobacco Or Other Nicotine Products
Chaffee (2020)
E-cigarette use and adverse respiratory symptoms among adolescents and Young adults in the United States.
Individual Clinical
Respiratory Toxicity
Relative Health Effect Of User
Chaffee (2021)
Biomarkers of nicotine exposure correlate with the hooked on Nicotine Checklist among adolescents in California, United States.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Chaffee (2022)
Preferences, use, and perceived access to flavored e-cigarettes among United States adolescents and young adults.
Population Clinical
Consumer Use
Youth Use & Appeal
Chaffee (2022)
E-cigarette, cannabis and combustible tobacco use: associations with xerostomia among California adolescents.
Individual Clinical
Safety
Adverse Effects
Chaffee (2023)
Flavors increase adolescents’ willingness to try nicotine and cannabis vape products.
Population Clinical
Consumer Use
Youth Use & Appeal
Chaffee (2023)
Electronic Cigarette Use and Progression From Experimentation to Established Smoking
Population Clinical
Likelihood Of Use
Current Smokers
Switching From
Tobacco Products
To Ends
Chaffee (2018)
Predictors of Smokeless Tobacco Susceptibility, Initiation, and Progression Over Time Among Adolescents in a Rural Cohort
Population Clinical
Consumer Use
Youth Use & Appeal
Chaffee (2019)